|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/107 | (2006.01) |
| A61K 9/0014 | (2013.01) | ||
| A61K 47/44 | (2017.01) | ||
| A61K 9/14 | (2013.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 47/44 | (2013.01) | ||
| A61K 9/14 | (2006.01) | ||
| A61P 23/02 | (2006.01) | ||
| A61K 9/1075 | (2013.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61K 31/167 | (2013.01) | ||
| A61K 31/616 | (2006.01) | ||
| A61K 31/192 | (2013.01) | ||
| A61K 31/192 | (2006.01) | ||
| A61K 31/616 | (2013.01) | ||
| A61K 31/167 | (2006.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 23/02 | (2018.01) | ||
| A61P 5/00 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61K 38/00 | (2006.01) | ||
| A61P 5/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Patento numeris | 2938324 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13869707.3 |
| Europos patento paraiškos padavimo data | 2013-12-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-11-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-11-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/077985 |
| Data | 2013-12-27 |
| (87) | Numeris | WO 2014/106048 |
| Data | 2014-07-03 |
| (30) | Numeris | Data | Šalis |
| 201261748036 P | 2012-12-31 | US | |
| 201361758726 P | 2013-01-30 | US |
| (72) |
JORDAN, Frederick, L. , US
JORDAN, Chris , US
|
| (73) |
JRX Biotechnology, Inc. ,
8502 E Chapman Ave., No. 648, Orange, CA 92869,
US
|
| (54) | LIQUID TOPICAL PHARMACEUTICAL NANO-EMULSION FORMULATIONS |
| LIQUID TOPICAL PHARMACEUTICAL NANO-EMULSION FORMULATIONS |